Roy Buchanan analyst JMP

Currently, out of the existing stock ratings of Roy Buchanan - 32 which are a Buy (100%)

Roy Buchanan

Work Performance Price Targets & Ratings Chart

Analyst Roy Buchanan works at JMP and is covering the Healthcare sector with 57 price targets and ratings displayed on 8 stocks.

Roy Buchanan's average stock forecast success ratio is 37.66% with an average time for price targets to be met of 88.43 days.

Most recent stock forecast was given on ENTA, Enanta Pharmaceuticals at 21-Nov-2023.

Wall Street Analyst Roy Buchanan

Analyst best performing recommendations are on ENTA (ENANTA PHARMACEUTICALS).
The best stock recommendation documented was for ENTA (ENANTA PHARMACEUTICALS) at 11/8/2021. The price target of $77 was fulfilled within 11 days with a profit of $17.24 (18.29%) receiving and performance score of 16.63.

Average potential price target upside

CVAC CureVac N.V. ENTA Enanta Pharmaceuticals HOOK HOOKIPA Pharma ARGX argenx SE ABUS Arbutus Biopharma DVAX Dynavax Technologies IBIO PRDS

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$4.44 (79.86%)


3 months 14 days ago

2/3 (66.67%)

$-1.82 (1.91%)




$18.76 (358.02%)


7 months 9 days ago

0/4 (0%)

$21.69 (222.23%)



$3.44 (61.87%)

10 months 26 days ago

1/1 (100%)

$-1.36 (-13.13%)




2 years 7 months 9 days ago

1/1 (100%)

$-81.95 (-63.55%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Roy Buchanan is most bullish on?

Potential upside of $13.08 has been obtained for DVAX (DYNAVAX TECHNOLOGIES)

Which stock is Roy Buchanan is most reserved on?

Potential downside of $3.97 has been obtained for ABUS (ARBUTUS BIOPHARMA)

What Year was the first public recommendation made by Roy Buchanan?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart